ALYREF and neuroblastoma: Endogenous knockdown of ALYREF in all neuroblastoma cells (Supplementary Fig. 1l) was accompanied by a significant decrease in cell viability (Supplementary Fig. 1m), as measured by Alamar Blue assay.